Parallax Volatility Advisers’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-54,800
Closed -$1.62M 2505
2023
Q4
$1.62M Buy
54,800
+53,000
+2,944% +$1.06M ﹤0.01% 1234
2023
Q3
$28.6K Sell
1,800
-183,400
-99% -$3.05M ﹤0.01% 2061
2023
Q2
$3.49M Buy
+185,200
New +$2.19M 0.01% 923
2022
Q2
Sell
-400
Closed -$2K 3395
2022
Q1
$2K Buy
+400
New +$2.21K ﹤0.01% 2762
2019
Q2
Sell
-200,000
Closed -$542K 3977
2019
Q1
$542K Buy
+200,000
New +$866K ﹤0.01% 1495

Other funds holding IMGN

Parallax Volatility Advisers's IMGN Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 100,000 shares — an estimated $1.18M sold.

Parallax Volatility Advisers first reported a position in IMGN in Q4 2017 and held it in 7 quarters. The position peaked at $384K in Q1 2023. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • Parallax Volatility Advisers reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 100,000 Immunogen Inc shares in Q2 2023, an estimated $1.18M.
  • Parallax Volatility Advisers first reported a position in Immunogen Inc in Q4 2017 and held it in 7 quarters.
  • Parallax Volatility Advisers's Immunogen Inc position peaked at $384K in Q1 2023.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.